Beetham Thomas W.

Track

Insider profile

Beetham Thomas W.'s trades of Viridian Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-04 2026-03-04
PrS Proposed sale
46,652
217.60
US$2,905,722 		46,652 217.60 US$2,905,722
2024-09-30 2024-09-27
PP Planned purchase
58,857 +42.9%
52.39
US$2,419,098 		58,857 +42.9% 52.39 US$2,419,098
2021-02-05 2021-02-03
PlS Planned sale
74,416 -49.7%
456.04
US$2,486,019 		74,416 -49.7% 456.04 US$2,486,019
2020-07-02 2020-07-01
PlS Planned sale
2,855 -100.0%
25.84
US$73,773 		2,855 -100.0% 25.84 US$73,773
2020-07-02 2020-07-01
PlS Planned sale
26,734 -90.4%
25.32
US$676,905 		26,734 -90.4% 25.32 US$676,905
2020-06-12 2020-06-10
PlS Planned sale
13,752 -31.7%
25.07
US$344,763 		13,752 -31.7% 25.07 US$344,763
2020-04-22 2020-04-21
PlS Planned sale
955 -3.1%
20.44
US$19,520 		955 -3.1% 20.44 US$19,520
2020-04-22 2020-04-21
PlS Planned sale
1,563 -4.9%
19.56
US$30,572 		1,563 -4.9% 19.56 US$30,572
2020-04-22 2020-04-20
PlS Planned sale
47,423 -59.6%
19.06
US$903,882 		47,423 -59.6% 19.06 US$903,882
2020-02-19 2020-02-14
PlS Planned sale
59 -0.1%
18.58
US$1,096 		59 -0.1% 18.58 US$1,096